Treatment Guidelines Materials

This fact sheet presents the 12 collaborative policies for HIV/TB being undertaken by the WHO.

This fact sheet presents the 12 collaborative policies for HIV/TB being undertaken by the WHO.

This report describes the updated guidelines for using nucleic acid amplification tests in the diagnosis of tuberculosis (TB).

This book discusses targeted tuberculin skin testing for latent TB infection as a strategic component of TB control. Specifically addressed are how to administer, read, and interpret the tuberculin skin test and its specificity and sensitivity. Continuing education credits are available.

This website is a comprehensive source of evidence syntheses, policies, guidelines, and research agendas on TB diagnosis. The website offers detailed guidance on how to conduct and report diagnostic research on TB, guidance on how to perform systematic reviews of diagnostics, tools on guideline development, including GRADE, and documents on improvement of laboratory quality and practice. All information is provided as open access, with no registration or fee requirements.

The TB course is intended as a refresher course for physicians (both public and private) that may be involved in the management and care of patients with TB. The course is developed as a preparation course to the MDR-TB course of WMA and both courses together offer a complete training module on TB. The refresher course will provide basic clinical care information for TB including the latest diagnostics, treatment and information about multidrug-resistant TB.

This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.

This slide set was developed as an accompaniment to the guidelines Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC.

This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.

This hospital discharge planning checklist may be used by health care workers to ensure that all of the appropriate steps have been taken in order to discharge a TB patient from the hospital.